Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-004228
Filing Date
2019-01-17
Accepted
2019-01-17 16:44:34
Documents
1
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4151
  Complete submission text file 0001209191-19-004228.txt   5607
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVASCIENCE, INC. 9 FOURTH AVENUE WALTHAM MA 02451
Business Address
Brinza Jeffery M. (Reporting) CIK: 0001760214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 19531363